What is the function of MrpL32 and do all of its activities require m-AAA proteolysis? Nolden et al. (2005) show that mitochondrial translation is diminished to a similar extent in the absence of either MrpL32 or a functional m-AAA protease. This indicates that the m-AAA protease is likely to control mitochondrial translation through processing of MrpL32 (Nolden et al., 2005), although this conclusion was not formally demonstrated. The reason for the drastic impact on mitochondrial translation is unclear. Processing of MrpL32 by the m-AAA protease results in a very tight association of MrpL32 with the mitochondrial inner membrane, even though no transmembrane domains are predicted. The association of MrpL32 with the inner membrane might serve to localize active ribosomes to the membrane, which may be important for efficient translation. Not all of the functions of MrpL32 require that it be processed given that large ribosomes still assemble without unprocessed MrpL32, in mitochondria with defective m-AAA protease. In contrast, in the absence of MrpL32, ribosomes, both large and small, fail to assemble. This implies that the incorporation of mature MrpL32 into the large ribosome is critical for translation in mitochondria. Alternatively, processed MrpL32 may exist in a complex independent of the large ribosome but still essential for mitochondrial translation. This latter possibility is supported by the observation that processed MrpL32 only partially comigrates with large ribosomal subunits in sucrose gradients. 
ADAM and Eph: How EphrinSignaling Cells Become Detached
Ephrin ligands presented on one cell surface associate with their receptors on the surface of a juxtaposed cell, often resulting in cell-cell repulsion. In this issue of Cell, Janes et al. (2005) show that the ephrin ligand can be proteolytically released from its membrane tether by a complex on the opposing cell composed of the ephrin receptor and an ADAM metalloprotease.
Ephrins are plasma membrane bound proteins that function as signaling ligands for a large family of receptor tyrosine kinases, the Eph receptors. Ephrin signaling guides cell migration and determines the path of cellular protrusions by influencing cell adhesion and organization of the cytoskeleton. Ephrin signaling has been well characterized in the nervous system where it has been shown to guide growing neuronal processes to their targets. For example, in the visual system, ephrin gradients regulate the spatial mapping of retinal ganglion cells to higher brain centers (Brown et al., 2000). However, ephrins have also been implicated in functions outside the nervous system, for example, in cell morphogenesis, tissue patterning, and angiogenesis (for a review on ephrin receptor signaling, see Pasquale, 2005).
Ephrins are characterized by an N-terminal extracellular receptor binding domain that adopts a globular β-barrel structure with "Greek-key" folding topology. Attachment of this domain to the membrane is preceded by a linker region of w40 amino acids. There are two subfamilies of ephrins: the A subclass, which is GPI anchored to the cell surface, and the B subclass, which is anchored by a single transmembrane segment followed by a short conserved cytoplasmic region ending with a PDZ binding motif ( loprotease domain, a disintegrin domain followed by a cysteine-rich region, and an EGF-like domain (see Figure 1) . A single-pass transmembrane segment leads to a cytoplasmic domain that often contains signaling motifs such as proline-rich regions and phosphorylation sites. Interestingly, although ADAMs exhibit specificity in the choice of their substrates, this specificity does not appear to reside in the proteolytic domain, which is able to cleave polypeptide chains without obvious preference for primary sequence (Blobel, 2005).
Flanagan and colleagues showed that, upon formation of the ephrin-A2/EphA3 signaling complex, KUZ catalyzed the proteolytic shedding of ephrin-A2 from its membrane tether. Furthermore, cultured neurons expressing a mutant ephrin-A2, which is competent for signaling but that cannot be proteolytically cleaved, failed to exhibit normal repulsive axon withdrawal effects (Hattori et al., 2000) . It is likely that the defect in this withdrawal function is due, at least in part, to an impairment of axon detachment.
In A key finding of the current report is that ADAM10 cleaves ephrin-A5 from its membrane tether only in trans. Thus, consistent with its constitutive association with the EphA3 receptor, ADAM10 must be presented by the juxtaposed cell. This is in contrast to other characterized ADAM-mediated proteolytic events, which so far have been shown only to occur in cis, that is, when both enzyme and substrate are expressed within the same cell (Blobel, 2005) . Thus, for ephrin-A5/EphA3, both initiation and termination of ephrin signaling proceed as intercellular events, dependent on the apposition of the cells expressing ligand and receptor. Although proposed previously (Blobel, 1997), ADAM10 appears to be the first example of a protease that cleaves its substrate in a manner that is cell nonautonomous.
In the ephrin system, the cell harboring the EphA3 receptor has the machinery to both initiate (via the receptor) and terminate (via the protease) the signal. Proteolysis in trans ensures that cleavage of the ephrin will occur only upon binding to its receptor on another cell. The proteolytic event that detaches ephrin-A5 from its membrane tether releases the adhesive bond between the two cells, allowing the cells to move apart. Furthermore, the postcleavage ephrin-A5/EphA3 complex is then endocytosed by the cell expressing the receptor. Given this example of ADAM-mediated proteolysis between cells that are attached through the interaction of ephrin-A5 and the EphA3 receptor, the questions arise: How general is this mechanism? Do other ephrin/ receptor pairs share the same fate? Do other ADAM proteases act on other ephrin pairs? Finally, as ADAM proteases appear to have many specific substrates despite the apparent lack of specificity in their protease domains, might these other ADAMs use a similar substrate recognition and activation mechanism involving the cysteine-rich domain as Janes et al. propose? It remains to be understood, for example, how the protease exerts its function in the context of oligomerized signaling pairs at the intercellular interface. Future investigations may begin to answer these questions and may also provide insight into the apparent requirement for higher-order clustering of signaling components.
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